Showing results (231-240 of 264) with videos related to

Sort By:
Pageof 27
Cancer Research|November 23, 2016
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast CancerVikram B Wali, Casey G Langdon, Matthew A Held, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2016
PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancerJaekwang Jeong, Joshua N VanHouten, Pamela Dann, et al.
Addictive Behaviors Reports|December 10, 2025
Associations between cannabis use frequency and suicidal thoughts and behaviors: A clinical longitudinal sibling studyElisa F Stern, Jarrod M Ellingson, Jonathan D Schaefer, et al.
European Child & Adolescent Psychiatry|March 10, 2017
'Emotiplay': a serious game for learning about emotions in children with autism: results of a cross-cultural evaluationS Fridenson-Hayo, S Berggren, A Lassalle, et al.
JACC. Cardiovascular Interventions|April 28, 2009
A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for QualityHarlan M Krumholz, Elizabeth H Bradley, Brahmajee K Nallamothu, et al.
BMC Research Notes|August 20, 2008
Contemporary evidence: baseline data from the D2B AllianceElizabeth H Bradley, Brahmajee K Nallamothu, Amy F Stern, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 28, 2021
Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participantsSarah D Lichenstein, Nick Manco, Lora M Cope, et al.
Pigment Cell & Melanoma Research|April 10, 2015
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitorsCasey G Langdon, Matthew A Held, James T Platt, et al.
Oncotarget|October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cellsCasey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Cancer Discovery|December 15, 2012
Genotype-selective combination therapies for melanoma identified by high-throughput drug screeningMatthew A Held, Casey G Langdon, James T Platt, et al.
Pageof 27